
Age-related impairments in antioxidant defences contribute to delayed tissue repair and increased susceptibility to oxidative stress following muscle injury. Glutathione (GSH), a key cellular antioxidant, plays a central role in redox homeostasis and recovery processes. GSH is synthesized through a sequential process involving glutamic acid and cysteine, catalyzed by the rate-limiting enzyme glutamate cysteine ligase (GCL) to form γ-glutamyl cysteine (γGC), which subsequently combines with glycine to produce GSH. Using metabolomic profiling and acute skeletal muscle injury in mice, this study characterized age-dependent alterations in GSH biosynthesis. Clustering analysis identified that muscle from 12-month-old mice have a delayed GSH synthesis profile in response to injury compared to 3-month-old mice, with an age-dependent delay in γGC accumulation. This suggests that aging negatively influences metabolite profiles within the GSH synthesis pathway. As γGC lies downstream of this enzymatic step, its supplementation may bypass the GCL bottleneck. To test this, C2C12 myoblasts were treated with γGC (from 1-100 µg/mL), however this did not affect myoblast proliferation or differentiation. These data suggest detrimental age-related dysregulation of GSH-related metabolites in skeletal muscle repair, particularly γGC, however further examination of the role of exogenous γGC supplementation in this process is required to identify further therapeutic benefit.
Adipose tissue dysfunction, chronic low-grade inflammation, and impaired metabolic regulation occur in aging. We examined the effects of caloric restriction (CR), endurance training (ET), and their combination on adipose macrophage-related gene expression and systemic metabolic indices in aged rats. Male rats (26-months-old) were randomized to control (CON), CR, ET, or CR+ET groups for a 6-week intervention (n = 9/group). CR consisted of a 30% reduction in food intake (weeks 1-2) followed by 20% restriction (weeks 3-6). ET was performed 5 days/week using a treadmill at 60% maximal aerobic speed. Epididymal adipose tissue was analyzed by RT-qPCR for CD11c and CD206 mRNA expression. Fasting glycemic and lipid-related variables were assessed. CR increased CD11c and CD206 expression, indicating non-specific upregulation of macrophage-associated transcription rather than a selective polarization shift. ET alone did not alter either marker relative to CON, but a combination with CR attenuated the CR-associated transcriptional response, particularly for CD11c. The CD11c/CD206 expression ratio showed greater variability with combined treatment. Fasting glucose, insulin, HOMA-IR, QUICKI, HOMA-β, TyG, conventional lipid parameters, and most atherogenic indices were not altered. CR and ET exert distinct effects on adipose macrophage-related gene expression in aged rats, whereas systemic metabolic markers remain largely unchanged.
Premature ovarian failure (POF) is characterized by ovarian dysfunction, infertility, and oxidative stress. Cinnamic acid (CA), a polyphenol with antioxidant properties, may protect ovarian function. This study evaluated the effects of CA in a D-galactose-induced mouse model of POF. Thirty NMRI mice were assigned to a control, a POF group, and three CA-treated groups (50, 100, and 200 mg/kg). POF was induced by daily D-galactose injection for 42 days, with CA co-administered during the last 14 days. Estrous cyclicity, ovarian histology, total antioxidant capacity (TAC), and mRNA expression of Nrf2, Foxo3a, Angpt1, Angpt2, and Vegfa were evaluated. D-gal disrupted estrous cycles, increased follicular atresia, and downregulated these genes. CA treatment improved estrous cyclicity, follicular development, and TAC, and increased gene expression relative to the POF group, with the most pronounced effects generally observed at 200 mg/kg. These findings suggest that CA may improve several features of D-galactose-induced ovarian dysfunction, potentially through enhanced antioxidant capacity. Changes in angiogenesis-related gene expression were inconsistent and should be considered exploratory rather than evidence of enhanced ovarian angiogenesis. Further protein-level, vascular, and functional studies are needed to clarify the biological significance and mechanisms of these effects.
Cardiovascular side effects are the leading cause of hospitalization/death in patients with diabetes. Saxagliptin is recommended for glycemic control in patients with Type-2-Diabetes-Mellitus (T2DM), while verapamil is preferred for cardiovascular disease. Although verapamil has been reported to exert blood glucose-lowering effects, its potential influence on the pharmacokinetics and glucose-lowering efficacy of saxagliptin has not yet been fully elucidated. This study aimed to investigate the effect of verapamil on the pharmacokinetics and blood glucose-lowering activity of saxagliptin in healthy and T2DM-model rats. Pharmacokinetic profiles of oral administration of saxagliptin (20 mg/kg) in rats with four groups (two healthy and two diabetic), with or without pretreatment of verapamil (10 mg/kg/day, PO, for 7 days), were examined. Also, blood glucose levels were analyzed to determine pharmacodynamic differences. Verapamil significantly increased the peak plasma concentration of saxagliptin in healthy and diabetic rats (from 4.8±1.07 to 6.96±1.22 μg/mL and from 6.05±1.68 to 8.24±1.2 μg/mL, respectively). Additionally, it was determined that blood glucose levels decreased with saxagliptin administration in all groups, and the decrease was higher in the verapamil-pretreated groups. The findings of this study may assist identify the best pharmacological combination effects of verapamil and saxagliptin in the treatment of diabetes.
Dietary fat perception influences food preference, satiety, and metabolic regulation but remains incompletely understood. This review examines current knowledge regarding receptor-mediated fat sensing, neural integration, adaptive plasticity, and their clinical implications. Evidence was collected from major biomedical databases through June 2026. Human and experimental studies addressing molecular receptors, psychophysical testing, electrophysiology, neuroimaging, genetics, and metabolic physiology were critically synthesized. CD36 and GPR120 function as principal lipid sensors alongside FFAR1, GPR84, FFAR2, and TGR5. Oral lipid detection is integrated with retronasal olfactory processing, trigeminal signaling, endocrine responses, and cortical reward networks. Fat perception demonstrates remarkable adaptability through receptor regulation, inflammatory remodeling, epigenetic modification, and dietary exposure. Methodological heterogeneity remains a major limitation across psychophysical and molecular investigations. Evidence supports a distributed, adaptive, and metabolically regulated system of dietary fat perception rather than an isolated sensory pathway. Improved methodological standardization and multidisciplinary approaches will accelerate translation into personalized dietary interventions and metabolic therapeutics.